Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome

International Journal of Hyperthermia

Volumn 24, Issue 6, 2008, Pages 475-482

  Chen, Qing ^a   Krol, Ava ^a   Wright, Alex ^a   Needham, David ^a   Dewhirst, Mark W ^b   Yuan, Fan ^a  

^a Duke University   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antivascular effects; Hyperthermia; Liposomes; Tumor microcirculation; Tumor microvascular permeability

Indexed keywords

DOXORUBICIN; LIPOSOME; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENCAPSULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; MOUSE; NONHUMAN; SOLID TUMOR; TEMPERATURE SENSITIVITY; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD FLOW VELOCITY; CAPILLARY PERMEABILITY; DOXORUBICIN; DRUG CARRIERS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; TEMPERATURE;

EID: 54449095389     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701854767     Document Type: Article

References (29)

1. Papahadjopoulos, D., Allen, TM, Gabizon, A., Mayhew, E., Matthay, K., Huang, SK, Lee, KD, Woodle, MC, Lasic, DD Redemann, C. et al. (1991) Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA, 88, pp. 11460-11464.
2. Ranson, M., Howell, A., Cheeseman, S. and Margison, J. (1996) Liposomal drug delivery. Cancer Treat Rev, 22, pp. 365-379.
3. Tardi, PG, Boman, NL and Cullis, PR (1996) Liposomal doxorubicin. J Drug Target, 4, pp. 129-140.
4. Gregoriadis, G. (1993) Liposome technology, CRC press, Boca Raton
5. Lasic, DD and Papahadjopoulos, D. (1995) Liposomes revisited. Science, 267, pp. 1275-1276.
6. Yuan, F., Leunig, M., Huang, SK, Berk, DA, Papahadjopoulos, D. and Jain, RK (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res, 54, pp. 3352-3356.
7. Jain, RK (2001) Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev, 46, pp. 149-168.
8. Chen, Q., Tong, S., Dewhirst, MW and Yuan, F. (2004) Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther, 3, pp. 1311-1317.
9. Needham, D. and Dewhirst, MW (2001) The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev, 53, pp. 285-305.
10. Kong, G., Anyarambhatla, G., Petros, WP, Braun, RD, Colvin, OM, Needham, D. Dewhirst, MW et al. (2000) Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res, 60, pp. 6950-6957.
11. Anyarambhatla, GR and Needham, D. (1999) Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: A new temperature-sensitive liposome for use with mild hyperthermia. J Liposome Res, 9, pp. 491-506.
12. Harris, L., Batist, G., Belt, R., Rovira, D., Navari, R., Azarnia, N., Welles, L. Winer, E. et al. (2002) Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma. Cancer, 94, pp. 25-36.
13. Needham, D., Anyarambhatla, G., Kong, G. and Dewhirst, MW (2000) A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res, 60, pp. 1197-1201.
14. Mayer, LD, Bally, MB and Cullis, PR (1986) Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta, 857, pp. 123-126.
15. Huang, Q., Shan, S., Braun, RD, Lanzen, J., Anyrhambatla, G., Kong, G., Borelli, M., Corry, P., Dewhirst, MW Li, CY et al. (1999) Noninvasive visualization of tumors in rodent dorsal skin window chambers. Nat Biotechnol, 17, pp. 1033-1035.
16. Kong, G., Braun, RD and Dewhirst, MW (2000) Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res, 60, pp. 4440-4445.
17. Yuan, F., Leunig, M., Berk, DA and Jain, RK (1993) Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res, 45, pp. 269-289.
18. Kong, G., Braun, RD and Dewhirst, MW (2001) Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res, 61, pp. 3027-3032.
19. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N. and Jain, RK (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA, 93, pp. 14765-14770.
20. Sandstrom, MC, Ickenstein, LM, Mayer, LD and Edwards, K. (2005) Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes. J Control Release, 107, pp. 131-142.
21. Gaber, MH, Wu, NZ, Hong, K., Huang, SK, Dewhirst, MW and Papahadjopoulos, D. (1996) Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys, 36, pp. 1177-1187.
22. Song, CW, Kang, MS, Rhee, JG and Levitt, SH (1980) Effect of hyperthermia on vascular function in normal and neoplastic tissues. Ann N Y Acad Sci, 335, pp. 35-47.
23. Gerlowski, LE and Jain, RK (1985) Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. Int J Microcirc Clin Exp, 4, pp. 363-372.
24. Huang, SK, Stauffer, PR, Hong, K., Guo, JW, Phillips, TL, Huang, A. Papahadjopoulas, D. et al. (1994) Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res, 54, pp. 2186-2191.
25. Yuan, F. (1998) Transvascular drug delivery in solid tumors. Semin Radiat Oncol, 8, pp. 164-175.
26. Netti, PA, Roberge, S., Boucher, Y., Baxter, LT and Jain, RK (1996) Effect of transvascular fluid exchange on pressure-flow relationship in tumors: A proposed mechanism for tumor blood flow heterogeneity. Microvasc Res, 52, pp. 27-46.
27. Lewis, JC, O'Flaherty, JT, McCall, CE, Wykle, RL and Bond, MG (1983) Platelet-activating factor effects on pulmonary ultrastructure in rabbits. Exp Mol Pathol, 38, pp. 100-108.
28. Clavijo, LC, Carter, MB, Matheson, PJ, Wilson, MA, Wead, WB and Garrison, RN (2001) PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. J Appl Physiol, 90, pp. 261-268.
29. Gewirtz, DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol, 57, pp. 727-741.